Theravance Biopharma, Inc. - Ordinary Shares (TBPH) by event type
TBPH moves most on rating reiterations — a median of +0.20% at 30 minutes across 27 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the TBPH overview →
How TBPH reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,808 of 2,717 | 16 | -0.13% | 44% | +0.14% |
| Analyst downgrades 1,215 of 2,603 | 35 | +0.03% | 54% | -0.06% |
| Coverage initiations 1,104 of 2,283 | 12 | 0.00% | 33% | +0.63% |
| Rating reiterations 455 of 3,522 | 27 | +0.20% | 67% | +0.40% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how TBPH usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · TBPH overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DBV Technologies S.A. - American Depositary Shares (DBVT) | 327 | -0.15% | 40% |
| Novartis AG (NVS) | 326 | +0.03% | 51% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.